Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria

•Complement inhibitor–naive patients with PNH had greater hemoglobin stabilization and LDH reduction with pegcetacoplan vs control.•Pegcetacoplan’s comprehensive control of hemolysis and favorable safety profile in these patients may help expand the treatment population. [Display omitted] Paroxysmal...

Full description

Bibliographic Details

Published in:	Blood advances Vol. 7; no. 11; pp. 2468 - 2478
Main Authors:	Wong, Raymond Siu Ming, Navarro-Cabrera, Juan Ramon, Comia, Narcisa Sonia, Goh, Yeow Tee, Idrobo, Henry, Kongkabpan, Daolada, Gómez-Almaguer, David, Al-Adhami, Mohammed, Ajayi, Temitayo, Alvarenga, Paulo, Savage, Jessica, Deschatelets, Pascal, Francois, Cedric, Grossi, Federico, Dumagay, Teresita
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 13.06.2023 The American Society of Hematology
Subjects:	Adult Antibodies, Monoclonal, Humanized - adverse effects Clinical Trials and Observations Complement Inactivating Agents - adverse effects Hemoglobins Hemoglobinuria, Paroxysmal - drug therapy Hemolysis Humans L-Lactate Dehydrogenase
ISSN:	2473-9529, 2473-9537, 2473-9537
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!